Holding(s) in Company

RNS Number : 3611U
Dechra Pharmaceuticals PLC
20 December 2011
 



 




TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Dechra Pharmaceuticals

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

Schroders plc

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

19.12.11

6. Date on which issuer notified:

20.12.11

7. Threshold(s) that is/are crossed or
reached:
vi, vii

16% - 15%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary

14,647,013

10,687,005

14,502,424

N/A

10,542,416

N/A

15.859%

GB0009633180

 


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

10,542,416

15.859%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Schroder Investment Management Limited                          9,925,509      14.931%

Schroder Investment Management North America Limited        616,907       0.928%

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:

The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements.

14. Contact name:

 

Taryn O'Donoghue

15. Contact telephone number:

 

020 7658 6000

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGMMZZVGMGMZM
UK 100

Latest directors dealings